Therapeutic Molecules From Moss with eleva's Andreas Schaaf and Björn Cochlovius, Ph.D.
Business Of Biotech
00:00
Oliva's Exotic Proteins
Oliva has established, as I said before, the process is very robust. They are now with working with 1000 liters and still there are plans to increase that further. And they have shown that what Andreas called difficult proteins, they were able to to do that and bring them even into the clinic. So that's is now for me the time point where it would make sense to go out to big farmer and talk about this new technology.
Transcript
Play full episode
